Jung YJ et al. |
Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. |
2017 |
Mol Oral Microbiol |
pmid:27484636
|
Kuroyanagi G et al. |
(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. |
2017 |
Prostaglandins Other Lipid Mediat. |
pmid:28163121
|
Chen X et al. |
Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. |
2017 |
Environ. Toxicol. Pharmacol. |
pmid:28738286
|
Hanmoto T et al. |
Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. |
2017 |
Biomed. Res. |
pmid:28239034
|
Fioramonti M et al. |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. |
2017 |
Oncotarget |
pmid:28223547
|
Xiong L et al. |
Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
2017 |
J. Cell Biol. |
pmid:28193701
|
Fortner RT et al. |
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. |
2017 |
BMC Med |
pmid:28173834
|
Chung ST et al. |
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. |
2017 |
Mol. Cancer |
pmid:28143606
|
Yin LL et al. |
Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. |
2017 |
Eur Rev Med Pharmacol Sci |
pmid:28121359
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|
Moran CS et al. |
Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966276
|
Cong Q et al. |
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. |
2016 |
Stem Cell Reports |
pmid:26947973
|
Wang C et al. |
Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. |
2016 |
Med. Sci. Monit. |
pmid:26939934
|
Alam I et al. |
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. |
2016 |
Endocrinology |
pmid:26584014
|
Liu G et al. |
Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. |
2016 |
Cell Tissue Res. |
pmid:26004143
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
Toffoli B et al. |
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. |
2016 |
Mediators Inflamm. |
pmid:28070143
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
Ugay L et al. |
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. |
2016 |
Chin. Med. J. |
pmid:27411457
|